Merck stock jumps 2.31% as company expands HIV treatment access through ADAPs

Traders Union
All News
Companies
Merck rises 2.31% today to $128.35

Highlights

MRK maintains a strong bullish trend across all timeframes, sharply outperforming key support levels after a 12.6% weekly surge.
Momentum and trend indicators signal ongoing buyer dominance, but multiple overbought readings warn of heightened short-term volatility.
Expect consolidation between $124 and $129, with a high probability of further gains if MRK breaks above $128.80 resistance.

Bullish alignment as price holds above key support zones

MRK is trading at $128.35, well above its MA-20 ($118.61), MA-50 ($115.83), and MA-200 ($106.33). This setup confirms a strong bullish structure across short-, medium-, and long-term trends. The Ichimoku Kijun on D1 stands at $120.17, which sits below current price and thus acts as immediate support. Near-term support lies at $120.17 (Kijun) and $115.83 (MA-50), while resistance is marked near $128.35 (current price region) and then above at the recent high, with no actionable MA resistance above price.

Overbought momentum as buyers extend rally to weekly highs

Momentum indicators underline strong upside: The MACD on D1 shows a clear buy signal, while ADX on D1 is neutral, indicating momentum is present but not yet accelerating. RSI at 69 and CCI at 226 both point to overbought conditions, as does Stoch RSI, signaling the risk of short-term pullbacks. BBP remains decisively positive, highlighting ongoing buyer dominance. Awesome Oscillator is neutral, not reinforcing the move. In today's session, MRK climbed 2.31%, with robust buying pressure pushing price to the top of the weekly range. Over the past week, MRK has risen $14.33 (12.57%), trading sharply higher from last week’s close at $114.02. The stock is now at the very top of its weekly range, with weekly volatility standing at 13.95%. The tone is markedly bullish, with price action extending directly to new 52-week highs.

Upside probability high as overbought signals flag volatility risk

For the coming week, the projected range is $124.36–$128.80, keeping MRK anchored just below its fresh 52-week high of $128.76 and far above the 52-week low at $76.66. Based on W1 indicators—RSI, ADX, MACD, and MA-50—which all signal "Buy," there is a very high probability (more than 80%) of further price increases, while downward moves appear much less likely. The baseline scenario sees MRK consolidating between $124 and $129. A bullish break above $128.80 could trigger further gains, while a drop below $124.36 would suggest a short-term correction. The broader trend remains bullish, though overbought technical signals caution that near-term volatility is likely.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Merck was experiencing persistent downside momentum, with weak technical signals reinforcing a cautious outlook. In light of ongoing market conditions, traders should monitor for any renewed buying interest that could signal a shift in the prevailing trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.